Abacus Health Products (ABAHF) Stock Price, News & Analysis

Company Overview

Abacus Health Products (OTCMKTS: ABAHF) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of prescription and over-the-counter (OTC) healthcare products. The company targets established therapeutic areas where existing safety and efficacy data can be leveraged to accelerate regulatory approval and market launch. By sourcing under-commercialized assets or products nearing patent expiry, Abacus aims to extend product lifecycles and deliver value to healthcare providers and consumers.

Abacus’s portfolio is built around topical and consumer-focused formulations, including treatments for dermatological conditions, pain management and common cold or flu symptoms. Products are manufactured under contract with North American facilities that meet regulatory standards, and Abacus works closely with licensing partners to secure distribution rights. This approach allows the company to focus its internal resources on marketing, regulatory support and sales channel development.

Headquartered in Canada, Abacus Health Products distributes its line-up across Canadian provinces and the United States, utilizing a combination of national pharmacy chains, independent drugstores and e-commerce platforms. The company’s commercial strategy is supported by a network of specialty sales representatives and digital marketing initiatives designed to educate healthcare professionals and consumers about product benefits. Abacus continues to explore new licensing and acquisition opportunities to expand its presence in selected niche markets.

Key Stats

• Today's Range: $4.60 to $5.50
• 50-Day Range: $4.84 to $4.84
• 52-Week Range: $1.12 to $8.40
• Volume: 9,300 shs
• Average Volume: 10,164 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ABAHF
• CIK: N/A
• Web: abacushp.com
• Phone: N/A
• Fax: N/A
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A